Effect of IFN-α on CC14-induced fibrosis of the liver and immune status in mice of different age

Bulletin of Experimental Biology and Medicine

Volumn 139, Issue 3, 2005, Pages 324-327

  Filimonov, P N ^b   Sukhenko, T G ^a   Gavrilova, N I ^b   Shkurupii, V A ^b  

^a NOVOSIBIRSK STATE MEDICAL UNIVERSITY   (Russian Federation)

^b ENERGY SYSTEMS INSTITUTE   (Russian Federation)

Author keywords

Age; CCI4; Fibrosis; IFN

Indexed keywords

ALPHA INTERFERON; CARBON TETRACHLORIDE; COLLAGEN;

AGE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL PROLIFERATION; CELL REGENERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; DRUG ACTIVITY; DRUG EFFICACY; HELPER CELL; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNE STATUS; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTOXICITY; LIVER CELL; LIVER FIBROSIS; LIVER TOXICITY; LOW DRUG DOSE; MALE; MORPHOMETRICS; MOUSE; NONHUMAN; PHAGOCYTOSIS; SPLEEN CELL; T LYMPHOCYTE; TRANSCRIPTION REGULATION;

AGING; ANIMALS; CARBON TETRACHLORIDE; CELLS, CULTURED; INTERFERON-ALPHA; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; MICE; MICE, INBRED C57BL;

EID: 22144442761     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10517-005-0284-4     Document Type: Article

References (15)

1. V. K. Verin, Arkh. Patol., 30, No.7, 49-53 (1968). 1:STN:280:CCaD28vmtlE%3D
2. A. Dalu, P. S. Rao, and H. M. Mehendale, Environ. Health Perspect., 106, No.9, 597-606 (1998). 1:CAS:528:DyaK1cXmvFWrsr0%3D
3. B. Delaney, S. C. Strom, S. Collins, and N. E. Kaminski, Toxicol. Appl. Pharmacol., 126, No.1, 98-107 (1994). 1:CAS:528:DyaK2cXjtFOmsLs%3D
4. J. Fort, C. Pilette, N. Veal, et al., J. Hepatol., 29, No.2, 263-270 (1998). 1:CAS:528:DyaK1cXmvVWlt7s%3D
5. R. Fukuda, N. Ishimura, and S. Ishihara, Liver, 16, No.6, 390-399 (1996). 1:STN:280:ByiC2szot1Q%3D
6. P. S. Guzelian and C. J. Henry, Similarities and Differences between Children and Adults: Implications for Risk Assessment, eds. P. S. Guzelian et al., Washington (1992), pp. 1-3.
7. Y. Inagaki, T. Nemoto, M. Kushida, et al., Hepatology, 38, 890-899 (2003). 1:CAS:528:DC%2BD3sXovFGhtbg%3D
8. F. Jahn, A. Reuter, E. Karge, et al., Exp. Toxicol. Pathol., 45, Nos. 2-3, 101-107 (1993). 1:CAS:528:DyaK3sXks1Gitbc%3D
9. D. Jirova, I. Sperlingova, M. Halaskova, et al., Cent. Eur. J. Public Health, 4, No.1, 16-20 (1996). 1:CAS:528:DyaK28Xjs1Slt7k%3D
10. A. Madro, M. Slomka, K. Celinski, et al., Ann. Univ. Mariae Curie Sklodowska [Med], 57, No.1, 55-60 (2002).
11. D. G. Reddy, K. R. Krishnamurthy, and G. R. Bhaskar, Arch. Pathol., 74, 73-80 (1962). 1:STN:280:CC2D1M3ks1w%3D
12. L. E. Rikans, K. R. Hornbrook, and Y. Cai, Mech. Aging Dev., 76, No.2-3, 89-99 (1994). 1:CAS:528:DyaK2MXis1Oqs7g%3D
13. Z. Shi, A. E. Wakil, and D. C. Rockey, Proc. Natl. Acad. Sci. USA, 94, 10,663-10,668 (1997).
14. P. P. Simeonova, R. M. Gallucci, T. Hulderman, et al., Toxicol. Appl. Pharmacol., 177, No.2, 112-120 (2001). 1:CAS:528:DC%2BD3MXovFGhu7w%3D
15. N. N. Zein, Cytokines Cell. Mol. Ther., 4, 229-241 (1998). 1:CAS:528:DyaK1MXltFOk